The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments.
about
Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.The Relation of HPV Infection and Expression of p53 and p16 Proteins in Esophageal Squamous Cells Carcinoma.p16(INK4a)/Ki-67 dual stain cytology for cervical cancer screening in Thika district, Kenya.Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.A Suggested Approach to Simplify and Improve Cervical Screening in the United States.Triage of HPV positive women in cervical cancer screening.p53 expression but not p16(INK4A) correlates with human papillomavirus-associated esophageal squamous cell carcinoma in Kazakh populationHuman papillomavirus infection and p16 expression in the immunocompetent patients with extragenital/extraungual Bowen's disease.Frequency of Chlamydia trachomatis infection in cervical intraepithelial lesions and the status of cytological p16/Ki-67 dual-staining.The time is now to implement HPV testing for primary screening in low resource settings.Triage of high-risk HPV positive women in cervical cancer screening.Local immune response depends on p16INK4a status of primary tumor in vulvar squamous cell carcinoma.5-aza-2'-deoxycytidine (DAC) treatment downregulates the HPV E6 and E7 oncogene expression and blocks neoplastic growth of HPV-associated cancer cells.HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status.A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancers.Two-grade Bethesda system of reporting in cervical screening: colposcopist's view.The causal role of human papillomavirus infections in non-anogenital cancers. It's time to ask for the functional evidence.p16(INK) (4a) expression as a potential marker of low-grade cervical intraepithelial neoplasia progression.Expression of p16 and human papillomavirus 16 with associated risk factors in cervical premalignant and malignant lesions
P2860
Q30241076-FE6A2A06-CC82-4866-BDB8-877746D57BC6Q33702362-C251B4FC-E1FD-40CD-8110-DAEFFCB432A7Q35936549-8A3BE59E-CDED-4A9B-BB1E-D5AC290D142BQ36159360-6B1C2011-B71F-46FE-8AF4-89A47B6A3F8DQ36407125-3179D012-C56B-4913-9C64-0EDD38D1F528Q36679896-F46964CC-1681-464A-901A-ECDE4F49D25DQ36793596-109C1613-AE5E-4904-A87E-AB7B7C8EEACDQ37035380-5ED37E85-702C-43B7-9555-D7B506B6BE66Q37569565-0CE7AB9D-584E-408E-88A5-50FA8AE1A35FQ38372381-B261984E-9275-433B-9676-A592774794B6Q38824019-DE0E4AAD-4017-41A2-81DA-3252414C7DCBQ40197685-F860D729-DAF9-4A49-A1F3-5F6B53523BADQ40651597-B5631FF5-8384-47B3-AD7E-8EFC9645038AQ40673772-26209C70-95E5-4F12-873F-F05D6C4F1F83Q40765193-8ADF177C-9C56-4C0C-B8FF-532B8DA7A544Q40833112-0D7BC6D4-EDCC-40F5-945A-907B38602D21Q42381513-61A74CEE-A295-4C31-947E-45D4217E7174Q42469683-4E9CD214-3E20-4C16-A762-83D3F7882F19Q59138473-F245E661-325C-4F3E-9C60-2DBE78AA0C07
P2860
The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The clinical impact of using p ...... update of recent developments.
@en
type
label
The clinical impact of using p ...... update of recent developments.
@en
prefLabel
The clinical impact of using p ...... update of recent developments.
@en
P2093
P2860
P356
P1476
The clinical impact of using p ...... update of recent developments.
@en
P2093
Christine Bergeron
Guglielmo Ronco
Magnus von Knebel Doeberitz
Marc Arbyn
Mark Stoler
Miriam Reuschenbach
P2860
P304
P356
10.1002/IJC.28900
P577
2014-05-12T00:00:00Z